Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zynex wins CE marking for NeuroMove and TruWave devices
Both NeuroMove and TruWave devices have previously received the FDA’s clearance for marketing in the US. NeuroMove is marketed for stroke and spinal cord injury rehabilitation and TruWave
Both NeuroMove and TruWave devices have previously received the FDA’s clearance for marketing in the US. NeuroMove is marketed for stroke and spinal cord injury rehabilitation and TruWave
Results also showed that for patients in the trial taking rosuvastatin: the combined risk of heart attack, stroke or cardiovascular (CV) death was reduced by nearly half (47%,
The CNAP Monitor 500 measures non-invasive and continuous blood pressure in real-time and can predict responsiveness to fluid administration. In the perioperative setting, detecting blood pressure drops and
Under the terms of the agreement the kits will be manufactured by Nanogen and branded as Menarini products. The first products are expected to be introduced to the
The DiaGenic BCtect breast cancer test will be marketed in India through Religare SRL (formerly known as SRL Ranbaxy), a laboratory chain in South East Asia. India was
Centre Hospitalier Universitaire d’Angers (CHU d’Angers) has received a grant from the Programme Hospitalier de Recherche Clinique – National, a program under the French Ministry of Health, to
In each Phase II study, VIA-2291 inhibited production of leukotrienes, proposed mediators of vascular inflammation. VIA-2291 was generally well-tolerated, the company said. According to the company, the first
With the addition of Mr Corbett and Mr Pelak, the Vertos board expands to six members. Mr Corbett has more than 28 years of leadership experience in the
AC-200, an endogenous human protein produced by bone cells, was evaluated in a rodent model of chronic kidney disease (CKD) in which bone loss is rapid and substantial.
The studies were undertaken at an independent research laboratory in the US with significant experience with visceral Leishmaniasis animal models. Dosages of 10mg/kg and 20mg/kg of iCo-009 were